Logo

Elucidata: Richard Kibbey, Nick Pullen, Avi Ma'ayan

Nov 21, 2019

Elucidata has formed a scientific advisory board comprising Richard Kibbey, Nick Pullen, and Avi Ma'ayan. Kibbey is associate professor of medicine (endocrinology) and cellular & molecular biology at the Yale School of Medicine. Pullen is the scientific cofounder of Elucidata, and has more than 20 years of experience in the pharmaceutical industry with Pfizer, Roche, and most recently Celgene. Ma'ayan is director of the Mount Sinai Center for Bioinformatics and a professor of bioinformatics in Mount Sinai's Department of Pharmacological Sciences.

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.